PATENT CLAIM ANALYSIS

Application Number: 16081275
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "054000"]

Abstract:
New methods for treating and/or preventing cardiovascular disease including, for example, myocardial infarction and atherosclerosis, by the use of at least one E-selectin inhibitor and compositions comprising the same are disclosed.

Claim (Index 10):
The method according to  claim 9 , wherein the necrotic core size of at least one atherosclerotic plaque within the subject is decreased.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15662546', '14775510', '13465691', '11892000', '14982863']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7716695195949375
- 35 USC 102 Novelty (BERT): 0.5085271416081477
- Combined Prediction Score: 0.7453552817962585
- Mean Citation Score: 222.81728200000003
- Max Citation Score: 240.04715
- Similarity Product: 151.66832710738774

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test